Guo-Hua Fong, PhDProfessor, Department of Cell BiologyCenter for Vascular Biology
|
Degree | Institution | Major |
---|---|---|
BSc | Zhejiang University | Biology |
PhD | University of Illinois | Molecular Biology |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Unversity of Alberta | Department of Biochemistry |
Postdoctoral | Samuel Lunenfeld Research Institute | Developmental Biology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
1997 - 2000 MRC Scholarship Award | Medical Research Council of Canada |
1989 - 1991 Killam Memorial Fellowship Award (Alberta) | |
1989 - 1991 Alberta Heritage Fellowship |
We are interested in developing angiogenesis-based approaches to treating type 2-diabetes, both by testing possible strategies in diabetic mice and through better understanding of fundamental aspects of blood vessel formation.
Project 1. Repair of injured vasculature in diabetic and non-diabetic mice. Type 2 diabetes has reached endemic levels, and leads to serious consequences such as heart attack, renal failure, blindness, amputation, and death. In spite decades of research, an effective treatment is still lacking. An important contributing factor to the devastating consequences of diabetes is loss and/or dysfunction of blood vessels in multiple tissues and organs. Destruction of blood vessels is not only a consequence of diabetic conditions, but also exacerbates the progression of diabetes because poor blood supply to multiple organs leads to further metabolic imbalance and therefore worsening of the disease. Thus, repair of diabetes-damaged blood vascular system treats both the symptom and cause.
Project 2. When blood vessels first form, they generally exist in a honeycomb pattern consisting of uniformly sized microvessels. To assume proper physiological functions, newly formed microvessels undergo extensive reorganization to form a tree-like hierarchical structure with clear distinctions of large trunks and progressively smaller branches. Very little is known about how this process is regulated, but yet such knowledge may be critical to the success of angiogenesis therapy. We are using the mouse retina as a model system to investigate the molecular and cellular mechanisms underlying this process.
Main technologies employed: manipulation of human induced pluripotent stem cells, genetic modification of mice, lentiviral vector-mediated overexpression and knockdown in mice, standard and live confocal imaging, microvascular surgery, laser Doppler imaging, conventional molecular biology and biochemistry, cell culture, and immunohistochemistry.
Not accepting students for Lab Rotations at this time
Journal Articles
-
Endothelial HIF2α suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling.
Development (Cambridge, England) 2024 Jun;151(11):
-
Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.
Nature cell biology 2023 Jul;25(7):950-962
-
Tailless and hypoxia inducible factor-2α cooperate to sustain proangiogenic states of retinal astrocytes in neonatal mice.
Biology open 2023 Jan;12(1):
-
Dependence of Retinal Pigment Epithelium Integrity on the NRF2-Heme Oxygenase-1 Axis.
Investigative ophthalmology & visual science 2022 Aug;63(9):30
-
Coupling of angiogenesis and odontogenesis orchestrates tooth mineralization in mice.
The Journal of experimental medicine 2022 Apr;219(4):
-
Oxygen-sensing mechanisms in development and tissue repair.
Development (Cambridge, England) 2021 Dec;148(23):
-
Isoform-specific roles of prolyl hydroxylases in the regulation of pancreatic β-cell function.
Endocrinology 2021 Oct;
-
Correction: Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.
The Journal of experimental medicine 2020 Sep;217(9):
-
Neuron-derived VEGF contributes to cortical and hippocampal development independently of VEGFR1/2-mediated neurotrophism.
Developmental biology 2020 Mar;
-
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
PLoS genetics 2019 Dec;15(12):e1008468
-
Developmental vascular pruning in neonatal mouse retinas is programmed in the astrocytic oxygen sensing mechanism.
Development (Cambridge, England) 2019 Mar;
-
Assembly of Bifunctional Aptamer-Fibrinogen Macromer for VEGF Delivery and Skin Wound Healing.
Chemistry of materials : a publication of the American Chemical Society 2019 Feb;31(3):1006-1015
-
Lacteal junction zippering protects against diet-induced obesity.
Science (New York, N.Y.) 2018 Aug;361(6402):599-603
-
Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.
The Journal of experimental medicine 2018 Feb;215(2):611-626
-
Retinal Angiogenesis Regulates Astrocytic Differentiation in Neonatal Mouse Retinas by Oxygen Dependent Mechanisms.
Scientific reports 2017 Dec;7(1):17608
-
Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.
Science translational medicine 2016 Mar;8(328):328ra29
-
Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.
Nature medicine 2016 Jan;22154-62
-
PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function.
The Journal of biological chemistry 2015 Jun;290(33):20580-9
-
Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling.
Journal of the American Society of Nephrology : JASN 2015 Jun;27428-38
-
Potential contributions of intimal and plaque hypoxia to atherosclerosis.
Current atherosclerosis reports 2015 Jun;17(6):510
-
Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.
Molecular and cellular biology 2015 May;35(15):2658-72
-
Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
Microvascular research 2015 Jan;97181-8
-
PTEN induces apoptosis and cavitation via HIF-2-dependent Bnip3 upregulation during epithelial lumen formation.
Cell death and differentiation 2014 Nov;22(5):875-84
-
Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.
The American journal of pathology 2014 Feb;184(4):1240-50
-
Improved vascular survival and growth in the mouse model of hindlimb ischemia by a remote signaling mechanism.
The American journal of pathology 2014 Jan;184(3):686-96
-
CD13 promotes mesenchymal stem cell-mediated regeneration of ischemic muscle.
Frontiers in physiology 2014 Jan;4402
-
Hypoxia inducible factor-2α regulates the development of retinal astrocytic network by maintaining adequate supply of astrocyte progenitors.
PloS one 2014 Jan;9(1):e84736
-
CD13 regulates anchorage and differentiation of the skeletal muscle satellite stem cell population in ischemic injury.
Stem cells (Dayton, Ohio) 2013 Dec;32(6):1564-77
-
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis.
Cancer research 2013 Aug;73(15):4781-90
-
Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.
Circulation research 2013 Apr;112(8):1135-49
-
Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice.
Circulation 2012 Aug;126(6):741-52
-
PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response.
The Journal of clinical investigation 2012 Aug;122(8):2827-36
-
Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization.
PloS one 2012 Jul;7(7):e41285
-
Silencing Prolyl Hydroxylase Domain Protein 3 Stabilizes Hypoxia Inducible Factor -1 Alpha and Preserves Myocardial Function Through The Activation of Pro-Angiogenic and Anti-Apoptotic Pathway Following Myocardial Injury In Mice
Current Pharmaceutical Design 2012 Jan;
-
Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
Antioxidants & redox signaling 2011 Oct;15(7):1789-97
-
Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice.
The American journal of pathology 2011 Apr;178(4):1881-90
-
Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice.
Blood cells, molecules & diseases 2010 Jun;45(1):9-19
-
Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application.
Tissue engineering. Part A 2009 Nov;15(11):3351-65
-
Cell-based therapy improves cell viability and increases airway size in an explant model.
Experimental lung research 2009 Aug;35(6):501-13
-
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2009 Apr;106(15):6152-7
-
Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Circulation research 2008 Aug;103(3):261-8
-
Role and regulation of prolyl hydroxylase domain proteins.
Cell death and differentiation 2008 Apr;15(4):635-41
-
VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.
Arteriosclerosis, thrombosis, and vascular biology 2008 Apr;28(4):658-64
-
Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.
Blood 2008 Mar;111(6):3229-35
-
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.
The Journal of clinical investigation 2008 Mar;118(3):913-23
-
Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Circulation 2007 Aug;116(7):774-81
-
Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2.
Molecular and cellular biology 2006 Nov;26(22):8336-46
-
Deficiency in the p110alpha subunit of PI3K results in diminished Tie2 expression and Tie2(-/-)-like vascular defects in mice.
Blood 2005 May;105(10):3935-8
-
Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability.
The Journal of biological chemistry 2005 May;280(19):19003-11
-
Endothelium-intrinsic requirement for Hif-2alpha during vascular development.
Circulation 2005 May;111(17):2227-32
-
Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.
Oncogene 2005 Feb;24(9):1510-24
-
Ischemic preconditioning-mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice.
Journal of molecular and cellular cardiology 2005 Feb;38(2):345-51
-
A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.
Development (Cambridge, England) 2004 Jun;131(11):2749-62
-
Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization.
Blood 2004 Feb;103(4):1370-2
-
Gastrulation and angiogenesis, not endothelial specification, is sensitive to partial deficiency in vascular endothelial growth factor-a in mice.
Biology of reproduction 2003 Dec;69(6):1852-8
-
VEGF-dependent conjunctivalization of the corneal surface.
Investigative ophthalmology & visual science 2003 Jan;44(1):117-23
-
The mouse Na+-K+-ATPase gamma-subunit gene (Fxyd2) encodes three developmentally regulated transcripts.
Physiological genomics 2001 Aug;6(3):129-35
Reviews
-
Regulation of angiogenesis by oxygen sensing mechanisms.
Journal of molecular medicine (Berlin, Germany) 2009 Jun;87(6):549-60
-
Mechanisms of adaptive angiogenesis to tissue hypoxia.
Angiogenesis 2008 Jan;11(2):121-40
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Regulation of VEGFR-2 Protein Abundance and Angiogenesis by VEGFR-1 | Talk | North American Vascular Biology Organization conference | 2011 | Cape Cod, Massachusetts |
Prolyl Hydroxylases as Promising Targets for Treating Retinopathy of Prematurity | Talk | Cleveland Clinic Foundation Eye Institute | 2010 | Cleveland, Ohio |
Role of Prolyl Hydroxylase in Maintaining Homeostasis in the Circulatory System | Talk | Keystone Symposia on Hypoxia | 2008 | Vancouver, Canada |
Regulation of Retinal Angiogenesis by PHDs | Talk | North American Vascular Biology Organization Conference | 2008 | Cape Cod, Massachusetts |
Intervention of Retinopathy of Prematurity by Manipulating the Hypoxia Pathway | Talk | National Institutes of Health/ National Eye Institute | 2007 | Bethesda, Maryland |
Role of HIF-Specific Prolyl Hydroxylases in the Homeostasis of the Circulatory System | Talk | National Institutes of Health/ National Cancer Institute | 2007 | Frederick, Maryland |
Evaluation of HIF-Specific Prolyl Hydroxylases as Putative Therapeutic Targets for Blood and Vascular Cells | Talk | Merck Research Laboratories | 2007 | Rahway, New Jersey |
Positive and Negative Roles of VEGFR Signaling in Vascular Development | Talk | Vascular Biology Symposium. Seminar presentation | 2004 | Charleston, South Carolina |
A Dual Role of VEGFR-1 in Mouse Embryogenesis | Talk | International symposium on vascular biology – vascular development and rege | 2003 | Fukouka, Japan |
Coordinated Functions of VEGF--A and its Receptors | Talk | Tohoku University, Institute of Development, Aging and Cancer | 2003 | Sendai, Japan |
VEGF-A Receptors Flt-1 and Flk-1 Mediate Two Distinct Signaling Pathways during Vasculogenesis | Talk | The XIIth International Conference of Vascular Biology | 2002 | Karuizawa, Japan |
Approaches to Developmental Biology of the Vascular System | Talk | International Symposium (satellite) of Angiogenesis | 2002 | Karuizawa, Japan |
Potentially Active Role of VEGFR-1 in Vasculogenesis | Talk | Gordon Conference (Angiogenesis) | 2001 | Rhode Island |
Role of the bHLH-PAS Domain Transcription Factor EPAS-1 (HIF-2a) in Vascular Remodeling | Talk | Great Lakes Meeting of Mammalian Development | 2000 | Toronto, Canada |
Endothelial Development as Regulated by Flt-1 and EPAS-1 | Talk | Center for Cardiovascular Development, Baylor College of Medicine | 2000 | Houston, Texas |
The Role of EPAS-1 Transcription Factor in Vascular Remodeling | Talk | Sunnybrook and Women’s Health Science Centre (University of Toronto) | 2000 | Toronto, Canada |
Vascular Pattern Formation During Mouse Embryogenesis | Talk | Wells Center for Pediatric Research, Indiana University School of Medicine | 2000 | Indianapolis, Indiana |
Molecular Controlling Mechanisms of Cardiovascular Development | Talk | Institute of Developmental Biology, Chinese Academy of Sciences | 1999 | Beijing, China |
Endothelial Differentiation and Vascular Pattern Formation in Mouse Embryos | Talk | Indiana University School of Medicine, Department of Biochemistry | 1999 | Indianapolis, Indiana |
Negative Regulation of Endothelial Differentiation by Flt-1 | Talk | Great Lakes Meeting of Mammalian Development | 1998 | Toronto, Canada |
Negative Regulation of Vascularization by VEGF Receptor-1 | Talk | Sunnybrook Health Science Centre, (University of Toronto) | 1998 | Toronto, Canada |
Role of VEGF Receptor in the Development of the Cardiovascular System | Plenary Lecture | Japanese Meeting of Blood, Brain and Heart Council | 1997 | Tokyo, Japan |
The Role of Flt-1 Receptor Tyrosine Kinase in Vascular Organization | Talk | Chiba University | 1997 | Chiba, Japan |
Embryonic Approaches to Blood Vessel Formation | Talk | Tohoku University | 1997 | Sendai, Japan |
Regulation of Endothelial Differentiation by VEGF Receptors | Talk | Department of Biochemistry, McMaster University. | 1997 | Hamilton, Canada |
Role of VEGF Receptor Flt-1 in Vascular Assembly | Talk | London Regional Cancer Centre | 1996 | London, Ontario, Canada |
VEGF and its Receptors in Signaling Vascular Development | Talk | Robarts Research Institute | 1995 | London, Ontario, Canada |